NCT00886600
A Study to Investigate the Magnitude and Duration of Response of MK0954 Compared to Placebo in Patients With Hypertension (0954-021)(COMPLETED)
See it on ClinicalTrials.gov ↗122 people
32%
68%
39 womenmiddle line = equal numbers83 men
- Phase
- PHASE3
- Paid for by
- Merck Sharp & Dohme LLC
- Finished
- 1992-08
- Health conditions
- Hypertension
- Who could join
- Anyone
- Ages
- 21 Years – no maximum
- Average age
- mean 53.5 years
- Age 65+
- Not reported
- Weight (BMI)
- Not reported
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 97.5% · Other 2.5%
Women left out
- No women who could get pregnant
Most women roughly 15–50 years old were turned away.
“Women of childbearing potential”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“History of chronic liver disease”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“History of myocardial infarction”
- No diabetes
Women with diabetes were turned away.
“Actively treated diabetes mellitus”
- No cancer
Women with current or past cancer were turned away.
“Secondary Hypertension or history of malignant hypertension”
Study titles and rules are shown in their original English.